简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-05-28 09:34 Olympus Acquires Israeli Medical Device Company Medi-Tate to Drive Global Urology Business Growth
2021-05-28 09:00 BIO KOREA 2021 International Convention to Unlock the Secret of Future Technologies
2021-05-27 15:43 Aptorum Group CEO Subscribed Shares In The Company
2021-05-27 14:22 Engine Biosciences Announces $43 Million Series A Round to Decipher Genetic Codes for New Medicines Through Machine Learning and Next-Generation Combinatorial Genetics
2021-05-26 19:09 Rapid Medical Announces Closing of $50m Series D Financing
2021-05-26 09:47 Ferring and Rebiotix Present Positive Interim Phase 3 Results From Open-Label Study of Investigational Microbiota-Based Live Biotherapeutic RBX2660 at Digestive Disease Week® (DDW)
2021-05-25 19:33 Aptorum Group Announces Positive Interim Phase I Clinical Trial Progress for ALS-4 Targeting Staphylococcus aureus and Positive Pre-IND Progress for SACT-1 Targeting Neuroblastoma
2021-05-25 15:14 Seoul Viosys’ Violeds Technology With Proven Virus Disinfection Adopted by SK magic
2021-05-25 12:45 Ferring and Rebiotix Present Landmark Phase 3 Data Demonstrating Superior Efficacy of Investigational RBX2660 Versus Placebo to Reduce Recurrence of C. difficile Infection
2021-05-25 10:51 Potential Impact of Takeda’s Dengue Vaccine Candidate Reinforced by Long-Term Safety and Efficacy Results
2021-05-25 09:54 Illumina and Microba Life Sciences Partner to Accelerate Microbiome Research
2021-05-24 18:55 Takeda Announces Approval of Moderna’s COVID-19 Vaccine in Japan
2021-05-24 16:53 Takeda to Present Positive Primary Analysis from Phase 2 OPTIC Trial of ICLUSIG® (ponatinib), Reinforcing Ability to Address Gaps in Care for Chronic-Phase CML
2021-05-24 11:29 Data from Merck’s Oncology Portfolio Highlight Significant Advances in Cancer Care at ASCO21
2021-05-24 09:39 CHMP issues positive opinion for Jardiance® (empagliflozin) for the treatment of adults with heart failure with reduced ejection fraction
2021-05-21 16:50 U.S. Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients With Cytomegalovirus Infection in Those Resistant and/or Refractory to Prior Anti-CMV Treatment
2021-05-21 14:57 Think-Lands: Four Fantastic Products Go on Sale in China!
2021-05-21 09:47 Takeda Presents Updated Results for Mobocertinib, Further Substantiating the Clinical Benefit in Patients with EGFR Exon20 Insertion+ mNSCLC
2021-05-20 13:32 NTT to Donate US$3M for Pandemic Relief to India
2021-05-18 18:36 Humanigen and Chime Biologics Enter Into Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab